Catcher Technology is actively pursuing strategic transformation and has recently announced that its subsidiary,Keli Biomedical, has acquired the Contract Development and Manufacturing Organization (CDMO) business assets of Gimer Medical through a business asset transfer.

Catcher Technology noted that Gimer Medical has extensive experience in the field of neuro-modulation research and development, possessing critical technologies and process capabilities that provide comprehensive customized and integrated services. In recent years, Gimer has actively participated in international exhibitions and has earned the trust of clients in implantable contract development technologies. This acquisition is expected to further enhance Catcher’s capabilities as it enters new domains.

Catcher Technology emphasized that, leveraging its core advantages in materials science and precision manufacturing, it has garnered considerable attention from numerous international brands in the consumer electronics sector. Since 2020, the company has been undergoing a strategic transformation, anticipating growth in smart healthcare and actively entering the advanced medical materials sector. Following this transaction, Catcher will acquire resources related to the research and development of implantable neuro-modulation devices, along with technology processes, patent certifications, and existing customer assets.

Looking ahead, Catcher Technology plans to continue its operations through organic growth and domestic and international mergers and acquisitions. The company aims to integrate cross-disciplinary platforms, leveraging its existing strengths in materials science and manufacturing to create synergies. It will gradually establish a supply chain ecosystem and core competitiveness in new fields while expanding its presence in the medical industry, with the goal of becoming a leader in the CDMO sector.

Resource (mandarin): 可成策略轉型再下一城！子公司可力生醫取得 CDMO 營業資產